Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease

Two randomized, placebo-controlled trials conducted in patients with nondialysis-dependent (NDD) chronic kidney disease (CKD), iron deficiency anemia, and normal or elevated serum phosphorus demonstrated that ferric citrate (FC) significantly increased hemoglobin and decreased serum phosphate concen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chertow, Glenn M., Block, Geoffrey A., Neylan, John F., Pergola, Pablo E., Uhlig, Katrin, Fishbane, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706696/
https://www.ncbi.nlm.nih.gov/pubmed/29186198
http://dx.doi.org/10.1371/journal.pone.0188712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706696/
https://www.ncbi.nlm.nih.gov/pubmed/29186198
http://dx.doi.org/10.1371/journal.pone.0188712

Ejemplares similares